| Authors: |
Frascarelli C; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Venetis K; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Marra A; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Mane E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Ivanova M; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Cursano G; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Porta FM; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Concardi A; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy., Ceol AGM; Department of Information and Communications Technology, European Institute of Oncology IRCCS, Milan, Italy., Farina A; Department of Information and Communications Technology, European Institute of Oncology IRCCS, Milan, Italy., Criscitiello C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology IRCCS, Milan, Italy., Guerini-Rocco E; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Fusco N; Division of Pathology, European Institute of Oncology IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy. |